Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ABL Diagnostics's Enterprise Value is €50.46 Mil.
ABL Diagnostics's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €0.16 Mil. Therefore, ABL Diagnostics's EV-to-EBIT ratio for today is 319.34.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, ABL Diagnostics's Enterprise Value is €50.46 Mil.
ABL Diagnostics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €0.48 Mil. Therefore, ABL Diagnostics's EV-to-EBITDA ratio for today is 104.90.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, ABL Diagnostics's Enterprise Value is €50.46 Mil.
ABL Diagnostics's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €11.63 Mil. Therefore, ABL Diagnostics's EV-to-Revenue ratio for today is 4.34.
ABL Diagnostics Enterprise Value Historical Data
The historical data trend for ABL Diagnostics's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ABL Diagnostics's Enterprise Value
For the Health Information Services subindustry, ABL Diagnostics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABL Diagnostics's Enterprise Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Enterprise Value distribution charts can be found below:
* The bar in red indicates where ABL Diagnostics's Enterprise Value falls into.
ABL Diagnostics Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
ABL Diagnostics's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABL Diagnostics (XPAR:ABLD) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
ABL Diagnostics's current Enterprise Value is €50.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ABL Diagnostics's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was €0.16 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
ABL Diagnostics's current Enterprise Value is €50.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ABL Diagnostics's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €0.48 Mil.
ABL Diagnostics's current Enterprise Value is €50.46 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ABL Diagnostics's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €11.63 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABL Diagnostics Enterprise Value Related Terms
Thank you for viewing the detailed overview of ABL Diagnostics's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:ABLD has been successfully added to your 